(Q24681516)

1

0 references

M Nakashima

2

0 references

K Sonoda

3

0 references

M Kikuchi

4

0 references

T Watanabe

Clinical and Experimental Immunology

5

0 references

language of work or name

English

0 references

publication date

March 2001

0 references

published in

0 references

volume

123

0 references

issue

3

0 references

page(s)

481-6

0 references

cites work

Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant?

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Labor-associated changes in Fas ligand expression and function in human placenta

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

The immunology of pregnancy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Is restricted antigen presentation the explanation for fetal allograft survival?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Unraveling immune privilege

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Complement and pregnancy: new insights into the immunobiology of the fetomaternal relationship

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Serological identification of human tumor antigens

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

HLA class I expression on the materno-fetal interface

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

The great balancing acts. The pregnant woman, placenta, fetus, and infectious agents

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

Expression of Fas-ligand in first trimester and term human placental villi.

30 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01461.X

T cell defined tumor antigens

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01461.X

The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906005

A role for CD95 ligand in preventing graft rejection

28 November 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01461.X

Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus

21 January 2018

1 reference

12 December 2020

Profile of cytokine mRNA expression in peri-implantation human endometrium

1 reference

12 December 2020

First trimester human endovascular trophoblast cells express both HLA-C and HLA-G

1 reference

12 December 2020

Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach

1 reference

12 December 2020

Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A

1 reference

12 December 2020

T cell awareness of paternal alloantigens during pregnancy

1 reference

12 December 2020

Decidual natural killer cytotoxicity decreased in normal pregnancy but not in anembryonic pregnancy and recurrent spontaneous abortion

1 reference

12 December 2020

Accounting for the peripartum loss of granulated metrial gland cells, a natural killer cell population, from the pregnant mouse uterus

1 reference

12 December 2020

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

12 December 2020

Human uterine natural killer cells

1 reference

12 December 2020